Ignite Creation Date:
2024-05-05 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00496743
Status:
TERMINATED
Last Update Posted:
2007-07-04
First Post:
2007-07-02
Brief Title:
Study of Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides
Sponsor:
Bispebjerg Hospital
Organization:
Bispebjerg Hospital
Study Overview
Official Title:
A Prospective Open-Label Study on Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides
Status:
TERMINATED
Status Verified Date:
2007-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The study was discontinued after the first 10 patients because of discouraging results
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpise of this study was to determine the effect of low-dose 4 Gy total skin electron beam therapy as a second-line treatment of stage IB-II mycosis fungoides
Detailed Description:
Current treatment modalities are usually not curative and having treatment options suitable for the long-term control therefore essential Electron beam therapy is generally applied to the skin in total doses of 30-36 Gy over a 8-10 week periodDue to the potential risk of toxicity including bone marrow supression no more than 2-3 courses in a life time are generally recommended In the current study we explored the possibility of using lower radiation doses for total skin electron beam therapy for long-term disease control
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None